Thad Stephens, MD
Undersea and Hyperbaric Medicine · Kansas City, MONPI 1053310938
Payments from drug & device makers
Across 387 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$1K
- Lifenet Health$987
- Integra Lifesciences Corporation$718
- Bioventus LLC$691
- Misonix Inc$689
- Hydrofera LLC$300
- plus $2K from 32 others
What the payments were for
- Food & beverage$6,683100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 187 | $1,472 |
| Lifenet Health | 27 | $987 |
| Integra Lifesciences Corporation | 40 | $718 |
| Bioventus LLC | 14 | $691 |
| Misonix Inc | 24 | $689 |
| Hydrofera LLC | 15 | $300 |
| Abbott | 3 | $190 |
| Paratek Pharmaceuticals, Inc. | 11 | $189 |
| Nevro Corp. | 3 | $177 |
| Melinta Therapeutics, LLC | 8 | $140 |
| Stryker | 1 | $114 |
| Convatec Inc. | 5 | $103 |
| KCI USA, Inc. | 5 | $90 |
| Molnlycke Health Care US, LLC | 4 | $78 |
| Acera Surgical, Inc. | 3 | $76 |
| 3M Company | 1 | $61 |
| Next Science LLC | 4 | $60 |
| Johnson & Johnson | 3 | $54 |
| Vertex | 2 | $52 |
| Medtronic(2 entities) | 3 | $46 |
| Coloplast | 2 | $41 |
| Boehringer Ingelheim | 3 | $37 |
| Bsn Medical Inc | 1 | $33 |
| Kerecis Limited | 2 | $31 |
| Organogenesis Inc. | 2 | $29 |
| Globus Medical | 1 | $27 |
| Solventum Corporation | 1 | $26 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $21 |
| Aroa Biosurgery Incorporated | 1 | $21 |
| Baudax Bio Inc. | 1 | $17 |
| Amgen | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $15 |
| Kestra Medical Technology Services, Inc. | 1 | $14 |
| Hartmann USA, Inc. | 1 | $13 |
| Nabriva Therapeutics, PLC | 1 | $11 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $11 |
| CSL Behring | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Other$143
- Senza$132
- TheraGenesis Wound Matrix$127
- PROCLAIM$126
- SALVATION$114
- SonicOne Clinic$113
How this compares
Too few undersea and hyperbaric medicine providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 47 | $103,693 |
| Gentamicin Sulfate | 100 | $4,003 |
| Linezolid | 24 | $3,762 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 72 | $1,305 |
| SsdSilver Sulfadiazine | 28 | $1,267 |
| Gabapentin | 103 | $1,166 |
| Silver Sulfadiazine | 34 | $988 |
| Triamcinolone Acetonide | 152 | $986 |
| Doxycycline Hyclate | 68 | $928 |
| Mupirocin | 122 | $808 |
| MupirocinMupirocin Calcium | 13 | $783 |
| Doxycycline Monohydrate | 33 | $459 |
| Levofloxacin | 99 | $388 |
| Cephalexin | 27 | $379 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 69 | $367 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $1,472 | $103,69347 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few undersea and hyperbaric medicine providers in Missourion file to place this against a meaningful peer group, so we don't.
Other undersea and hyperbaric medicine in Kansas City
- Craig GoldsteinKansas City$4K
- Jeffrey AlthoffKansas City$776
- Jason ForbesSpringfield$7K
- Valinda AllenSaint Louis$2K
- Gillian JonesSaint Joseph$2K
- Viktor BalladaSaint Louis$1K
- Maxine TheriotPoplar Bluff$758
- David DickersonBlue Springs$728
- Ameet DeshmukhBlue Springs$526
- Steven OrrSaint Joseph$469
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.